Table 5.
RT-PCR Analysis for TARC, CCR4, and CCR8 on Hodgkin and Non-Hodgkin Tumor Samples
| Tissue | Number of cases | TARC | CCR4 | CCR8 |
|---|---|---|---|---|
| Lymph node* | 1 | + | ± | + |
| Lymph node† | 1 | − | + | + |
| MC Hodgkin | 4 | + | + | + |
| NS Hodgkin | 8 | + | + | + |
| NLP Hodgkin | 6 | − | + | + |
| PKC‡ | 1 | − | + | + |
| Anaplastic B-cell | 6 | − | + | + |
| Anaplastic T/0-cell | 4 | − | + | + |
| TCRBCL | 3 | − | + | + |
| TCRBCL§ | 2 | + | + | + |
*Lymph node with dermatopathic lymphadenopathy.
†Lymph node with follicular and diffuse hyperplasia.
‡Progressively transformed germinal centers and follicular hyperplasia.
§For one of the two cases expression of TARC was determined only by in situ hybridization because no frozen tissue was available.